Position in GILD
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$30,090,145
-$7,112,028 QoQ
Shares Held
238,168
-10.8% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#276
of 2,265 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026XPONANCE LLC holds $673,665,379 across 15 Drug Manufacturers - General names. GILD ranks #6 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
222,559 | $266,943,963 | |
| 2 | JNJ |
Johnson & Johnson
|
466,851 | $118,566,148 | |
| 3 | ABBV |
AbbVie Inc.
|
350,912 | $88,303,495 | |
| 4 | MRK |
Merck & Co., Inc.
|
473,483 | $60,842,565 | |
| 5 | AMGN |
Amgen Inc
|
133,818 | $48,458,174 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
238,168 | $30,090,145 | |
| 7 | PFE |
Pfizer Inc
|
1,108,420 | $26,690,753 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
444,025 | $25,584,720 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,090,145 | 238,168 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $37,202,173 | 266,931 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $29,149,645 | 237,491 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $24,972,225 | 224,975 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $24,433,974 | 220,384 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $24,870,618 | 221,960 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $17,847,361 | 193,216 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $16,260,935 | 193,952 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $13,374,902 | 194,941 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $14,352,678 | 195,941 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $15,103,747 | 186,443 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $12,947,833 | 172,776 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $13,187,755 | 171,114 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $14,300,294 | 172,355 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $14,483,324 | 168,705 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $9,216,054 | 149,393 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $6,787,479 | 109,812 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $5,393,957 | 90,731 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $6,262,322 | 86,246 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $4,673,174 | 66,903 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $5,024,369 | 72,965 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $7,051,908 | 109,112 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $6,322,083 | 108,515 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $6,796,842 | 107,562 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $9,187,251 | 119,408 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||